ribavirin has been researched along with Christmas Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barcelo de Brito, S; Campos-de-Magalhães, M; Cecília da Fonseca Salgado, M; Eduardo Brandão-Mello, C; José de Almeida, A; Lúcia Elias Pires, M | 1 |
Bouhasin, J; Kane, R; Puetz, J; Thrower, M | 1 |
Honda, T; Kojima, T; Matsushita, T; Takamatsu, J; Yamamoto, K | 1 |
Altisent, C; Esteban, JI; Esteban, R; Guardia, J; Puig, L; Sauleda, S | 1 |
Kimura, S; Makuuchi, M; Morisawa, Y; Oka, S; Sugawara, Y; Tachikawa, N | 1 |
5 other study(ies) available for ribavirin and Christmas Disease
Article | Year |
---|---|
Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin.
Topics: Antiviral Agents; Autoantibodies; Drug Therapy, Combination; Factor IX; Factor VIII; Hemophilia A; Hemophilia B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and haemophilia followed at a pediatric haemophilia treatment center.
Topics: Antiviral Agents; Drug Therapy, Combination; Hemophilia A; Hemophilia B; Humans; Infant; Interferon-alpha; Male; Ribavirin; Treatment Outcome; Viral Load | 2004 |
Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin.
Topics: Adult; Antiviral Agents; Cells, Cultured; Factor VII; Gene Expression; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Male; Middle Aged; Ribavirin; RNA, Messenger | 2006 |
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Alanine Transaminase; Antiviral Agents; Blood Coagulation Disorders; Child; Chronic Disease; Drug Therapy, Combination; Factor VII Deficiency; Female; Hemoglobins; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C; HIV Antibodies; HIV Seronegativity; Humans; Interferons; Male; Middle Aged; Neutrophils; Platelet Count; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; von Willebrand Diseases | 2000 |
[Living donor liver transplantation in a patient with HIV].
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Therapy, Combination; Hemophilia B; Hepatitis C, Chronic; HIV Seropositivity; HIV-1; Humans; Interferon-alpha; Liver Transplantation; Living Donors; Male; Middle Aged; Ribavirin; Treatment Outcome | 2002 |